diseas
viru
fmdv
prototyp
member
belong
aphthoviru
genu
famili
picornavirida
viru
genom
kb
rna
contain
one
open
read
frame
viru
antigen
highli
variabl
seven
serotyp
c
diseas
viru
fmdv
caus
econom
import
highli
contagi
diseas
anim
cattl
swine
make
viru
monitor
world
organ
anim
health
oie
current
fmd
vaccin
tradit
way
protect
diseas
greatli
reduc
occurr
howev
use
fmd
vaccin
protect
earli
infect
limit
vaccin
take
protect
effect
addit
north
america
western
europ
consid
region
anim
vaccin
therefor
altern
strategi
appli
antivir
agent
requir
control
spread
fmdv
outbreak
situat
previou
studi
lithium
chlorid
licl
drug
treatment
bipolar
disord
depress
alzheim
diseas
found
fractur
heal
rodent
model
recent
report
show
licl
antivir
effect
number
virus
bronchiti
coronaviru
ibv
avian
coronaviru
transmiss
gastroenter
viru
tgev
pseudorabi
herpesviru
viru
also
belong
famili
new
report
porcin
reproduct
respiratori
syndrom
viru
prrsv
mammalian
suggest
licl
potenti
becom
antivir
drug
nevertheless
unclear
whether
licl
inhibitori
effect
fmdv
studi
identifi
fmdv
replic
significantli
inhibit
licl
fmdv
preserv
provid
oienat
diseas
refer
laboratori
china
babi
hamster
kidney
cell
obtain
american
type
cultur
collect
atcc
grown
dulbecco
modifi
eagl
medium
dmem
gibco
grand
island
ny
contain
fetal
bovin
serum
fb
licl
purchas
prepar
dmem
concentr
steril
filter
store
use
viral
titer
lysat
experi
calcul
tissu
cultur
infect
dose
reed
muench
method
briefli
cell
lysat
serial
dilut
dmem
cultiv
cell
five
replic
calcul
accord
well
number
cytopath
effect
cpe
grow
h
viral
yield
lysat
experi
confirm
briefli
total
rna
cell
lysat
extract
trizol
reagent
invitrogen
carlsbad
ca
accord
instruct
manufactur
cdna
obtain
thermo
scientif
revert
aid
first
strand
cdna
synthesi
kit
thermo
scientif
waltham
gene
fmdv
target
quantit
pcr
specif
primer
gadph
aag
act
gaa
ccc
act
aat
ctg
ttg
tta
ctt
gga
use
quantit
pcr
perform
use
pcr
system
appli
biosystem
foster
citi
ca
sybr
select
master
mix
kit
appli
biosystem
accord
instruct
manufactur
rel
mrna
express
level
calcul
use
method
normal
intern
control
mean
mrna
level
group
set
cellswel
cell
cultur
plate
grown
dmem
fb
cytotox
assay
perform
cell
count
donjindo
japan
accord
instruct
manufactur
briefli
cell
cell
cultur
plate
wash
three
time
pb
seri
concentr
licl
mm
ad
dmem
six
wellsdilut
h
cell
use
control
wash
three
time
pb
cell
incub
medium
solut
h
optic
densiti
od
valu
well
wavelength
nm
measur
micropl
reader
hercul
ca
rel
cell
viabil
rate
determin
concentr
drug
control
licl
concentr
cytotox
concentr
concentr
inhibit
prolifer
exponenti
grow
cell
decid
concentr
antivir
activ
licl
fmdv
determin
follow
protocol
triplic
cell
monolay
seed
cell
cultur
plate
infect
fmdv
moi
presenc
seri
concentr
mm
licl
h
control
triplic
cell
monolay
infect
fmdv
moi
absenc
drug
remov
uncombin
virus
wash
three
time
pb
cell
lysat
one
group
prepar
three
cycl
viral
yield
calcul
viral
inhibit
time
cours
licl
fmdv
determin
follow
protocol
viral
attach
stage
monolay
cell
seed
plate
infect
fmdv
moi
treat
seri
concentr
mm
licl
h
temperatur
mere
allow
virus
absorb
surfac
cell
control
cell
infect
fmdv
moi
absenc
drug
remov
uncombin
virus
pb
cell
lysat
prepar
three
cycl
viral
yield
detect
viral
entri
stage
monolay
cell
seed
cell
cultur
plate
infect
fmdv
moi
h
allow
viru
attach
remov
uncombin
viru
pb
cell
treat
treat
seri
concentr
mm
licl
h
control
cell
infect
fmdv
moi
absenc
drug
subsequ
drug
remov
cell
grown
fresh
medium
h
cell
lysat
prepar
three
cycl
viral
yield
calcul
viral
replic
stage
monolay
cell
seed
plate
infect
fmdv
moi
h
allow
viru
entri
remov
uncombin
viru
pb
cell
treat
seri
concentr
mm
licl
h
control
cell
infect
fmdv
moi
absenc
drug
subsequ
cell
lysat
prepar
three
cycl
viral
yield
calcul
monolay
cell
seed
plate
infect
fmdv
moi
h
cell
wash
three
time
pb
grown
fresh
medium
set
h
mm
nontox
concentr
licl
ad
cell
time
interv
h
post
infect
includ
phase
viru
replic
cell
wash
three
time
pb
grown
fresh
medium
end
time
interv
cell
lysat
prepar
three
cycl
viral
yield
calcul
h
post
infect
data
present
mean
standard
deviat
sd
least
triplic
experi
statist
signific
analyz
use
student
signific
differ
consid
p
statist
analysi
graphic
illustr
produc
softwar
graphpad
prism
version
exclud
possibl
cytotox
licl
impact
fmdv
infect
cytotox
assay
perform
accord
instruct
manufactur
cell
viabil
cell
treat
licl
concentr
mm
viabil
cell
treat
licl
concentr
mm
fig
licl
concentr
mm
signific
differ
drug
treat
cell
cell
cell
morpholog
data
shown
licl
concentr
mm
decid
concentr
licl
antivir
research
determin
antivir
activ
licl
fmdv
seri
concentr
mm
licl
ad
fmdv
infect
cell
final
viral
yield
cell
detect
qpcr
mean
viral
titer
mm
cell
respect
fig
mean
rel
mrna
yield
mm
cell
cell
set
respect
fig
result
viral
yield
indic
fmdv
viral
titer
decreas
respons
cell
treat
licl
viral
attach
entri
assay
perform
determin
whether
licl
affect
fmdv
attach
entri
stage
cell
viral
attach
assay
mean
viral
titer
mm
cell
respect
fig
mean
rel
mrna
yield
mm
cell
cell
set
respect
fig
viral
entri
assay
mean
viral
titer
mm
cell
respect
fig
mean
rel
mrna
yield
mm
cell
cell
set
respect
fig
result
viral
yield
indic
licl
affect
fmdv
attach
stage
entri
stage
viral
replic
assay
analyz
determin
whether
licl
affect
fmdv
replic
stage
cell
mean
viral
titer
mm
cell
respect
fig
mean
rel
mrna
yield
mm
cell
cell
set
respect
fig
result
viral
yield
indic
licl
antivir
effect
replic
fmdv
replic
time
cours
assay
perform
determin
time
cours
fmdv
replic
influenc
licl
licl
ad
cell
seri
time
interv
h
mean
viral
titer
time
interv
h
mm
cell
respect
fig
mean
rel
mrna
yield
time
interv
h
mm
cell
cell
set
respect
fig
result
viral
yield
indic
licl
antivir
effect
earli
stage
fmdv
replic
previous
report
licl
antivir
effect
agaist
serval
viru
vitro
ibv
avian
coronaviru
tgev
herp
simplex
viru
pseudorabi
herpesviru
prrsv
indic
licl
potenti
antivir
agent
studi
concentr
licl
rang
mm
compar
cell
cell
show
signific
toxic
signific
differ
cell
morpholog
firstli
licl
inhibit
fmdv
replic
fmdv
infect
cell
secondli
differ
viral
cycl
treat
licl
investig
viral
cycl
fmdv
infect
sensit
licl
found
licl
effect
fmdv
attach
entri
cell
indic
licl
directli
affect
connect
viru
cell
receptor
passageway
virus
cell
nevertheless
licl
significantli
inhibit
fmdv
replic
stage
cell
thirdli
investig
time
cours
fmdv
replic
stage
affect
licl
treatment
cell
expos
licl
sever
point
viral
replic
stage
found
licl
reduc
fmdv
replic
treat
within
hpi
suggest
earli
time
viral
replic
target
antivir
effect
licl
earli
time
viral
replic
stage
time
viral
rna
viral
protein
synthes
indic
licl
inhibit
viral
rna
viral
protein
synthes
licl
often
prescrib
drug
modern
result
reduct
viral
protein
synthesi
yield
releas
viral
progeni
cell
licl
led
decreas
progeni
viru
effect
viral
protein
treatment
might
use
food
anim
food
safeti
use
licl
medicin
also
import
problem
order
minim
risk
licl
toxic
care
monitor
adjust
licl
dosag
especi
import
conclus
fmdv
replic
stage
inhibit
licl
besid
licl
target
antivir
effect
earli
phase
fmdv
replic
fmdv
caus
econom
import
highli
contagi
diseas
anim
use
fmdv
vaccin
protect
earli
infect
limit
fmdv
mutat
frequent
escap
immun
resulst
reveal
tha
licl
potenti
effect
drug
therefor
licl
may
effect
drug
control
fmdv
base
mechan
antivir
effect
licl
fmdv
infect
need
research
vivo
